Patients were randomized ( @:@ ratio ) to receive pemetrexed @ mg/m ( @ ) intravenously once every @ weeks plus either oral pazopanib @ mg daily or cisplatin @ mg/m ( @ ) intravenously once every @ weeks up to six cycles .